Skip Navigation

Rheumatoid Arthritis

Citations 1-10 of 680 total displayed.

Most recent content (1 Sep 2008):

REVIEWS
Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity
H. P. Carroll, V. Paunovic, and M. Gadina
Rheumatology 2008; 47: 1269-1277. [Abstract] [Full Text]  

REVIEWS
Hypertension in rheumatoid arthritis
V. F. Panoulas, G. S. Metsios, A. V. Pace, H. John, G. J. Treharne, M. J. Banks, and G. D. Kitas
Rheumatology 2008; 47: 1286-1298. [Abstract] [Full Text]  

BASIC SCIENCE
Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis
Y. Yang, N. Lu, J. Zhou, Z.-n. Chen, and P. Zhu
Rheumatology 2008; 47: 1299-1310. [Abstract] [Full Text]  

BASIC SCIENCE
A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis
S. Kobayashi, H. Okamoto, T. Iwamoto, Y. Toyama, T. Tomatsu, H. Yamanaka, and S. Momohara
Rheumatology 2008; 47: 1317-1322. [Abstract] [Full Text]  

BASIC SCIENCE
A role for the integrin {alpha}6β1 in the differential distribution of CD4 and CD8 T-cell subsets within the rheumatoid synovium
O. Haworth, D. L. Hardie, A. Burman, G. E. Rainger, B. Eksteen, D. H. Adams, M. Salmon, G. B. Nash, and C. D. Buckley
Rheumatology 2008; 47: 1329-1334. [Abstract] [Full Text]  

CLINICAL
Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population
Y. Takizawa, S. Inokuma, Y. Tanaka, K. Saito, T. Atsumi, M. Hirakata, H. Kameda, S. Hirohata, H. Kondo, S. Kumagai, and Y. Tanaka
Rheumatology 2008; 47: 1373-1378. [Abstract] [Full Text]  

CLINICAL
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study
G. Karanikolas, D. Charalambopoulos, G. Vaiopoulos, A. Andrianakos, A. Rapti, D. Karras, E. Kaskani, and P. P. Sfikakis
Rheumatology 2008; 47: 1384-1388. [Abstract] [Full Text]  

CLINICAL
The importance of the baseline Disease Activity Score 28 in determining responders and non-responders to anti-TNF in UK clinical practice
N. Smith, T. Ding, S. Butt, K. Gadsby, and C. Deighton
Rheumatology 2008; 47: 1389-1391. [Abstract] [Full Text]  

LETTERS TO THE EDITOR
Tolerability of methotrexate and leflunomide combination therapy for inflammatory arthritis in routine clinical practice: results of a four-centre study
A. Kaul, D. T. O’Reilly, R. K. Slack, D. Collins, J. Walmsley, O. Duke, and P. D. W. Kiely
Rheumatology 2008; 47: 1430-1431. [Extract] [Full Text]  

CASE REPORTS
Repairing erosions in rheumatoid arthritis. A realistic goal
L. Silva, M. Fernández-Castro, and J.-L. Andreu
Rheumatology 2008; 47: 1432-1433. [Extract] [Full Text]  

[Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

* Collected Resources Home